Technology | 2009.10.29
NeuroVigil and Roche Launch Personalized Neurodiagnostics Initiative for Enabling Preventive Treatment of CNS Disorders
SAN DIEGO--(BUSINESS WIRE)--Today, leading California Neurotechnology company NeuroVigil and Swiss Pharma giant Roche announced an agreement regarding a major innovation in collecting and analyzing data from clinical trials. NeuroVigil will provide Roche with its iBrain devices and accompanying software analysis services to help speed up Roche’s drug development for various CNS disorders. NeuroVigil’s advanced portable, noninvasive iBrainTM devices will be used to monitor neural acti
For more information, please visit
http://www.businesswire.com/news/home/20091029006300/en
